Literature DB >> 8482973

Cerebrospinal fluid proteins in patients with leucoaraiosis: possible abnormalities in blood-brain barrier function.

L Pantoni1, D Inzitari, G Pracucci, F Lolli, G Giordano, L Bracco, L Amaducci.   

Abstract

Some CSF protein abnormalities have been proposed as a possible marker for vascular dementia. We studied the CSF protein levels and albumin ratio in 21 patients (mean age 64.04 +/- 7.5) with progressive bilateral motor impairment, and a CT picture of leucoaraiosis. Seven of these patients also presented with dementia. Twenty-seven Alzheimer's disease patients (mean age 59.59 +/- 5.30) without leucoaraiosis were taken as controls. We also evaluated the correlations of the albumin ratio values with the diagnosis of dementia, the severity of cognitive impairment, the degree of cerebral atrophy and presence of infarcts on CT, and the abnormalities in CSF circulation, found on isotopic cisternography, in the leucoaraiosis group. After controlling for age and sex, the patients with leucoaraiosis showed greater CSF albumin levels (0.27 g/l +/- 0.11 vs. 0.21 g/l +/- 0.06; covariance analysis P = 0.066), CSF IgG values (4.68 mg/100 ml +/- 1.45 vs. 2.85 mg/100 ml +/- 1.03; covariance analysis P < 0.001), and a higher albumin ratio (0.0078 +/- 0.0027 vs. 0.0058 +/- 0.0019; covariance analysis P = 0.013) than those with Alzheimer's disease. The variations of these parameters were not apparently related to the presence of dementia in the leucoaraiosis group. A significantly higher albumin ratio was observed in patients with a slowed CSF circulation compared to those with normal CSF circulation (0.0086 +/- 0.0028 vs. 0.0059 +/- 0.0019; covariance analysis P = 0.05). We conclude that, independently from the presence of dementia, patients with leucoaraiosis have CSF abnormalities consistent with functional blood-brain barrier alterations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8482973     DOI: 10.1016/0022-510x(93)90214-j

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

Review 1.  Circulating biologic markers of endothelial dysfunction in cerebral small vessel disease: A review.

Authors:  Anna Poggesi; Marco Pasi; Francesca Pescini; Leonardo Pantoni; Domenico Inzitari
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI.

Authors:  H S Markus; D J Lythgoe; L Ostegaard; M O'Sullivan; S C Williams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

3.  Age-related white matter changes.

Authors:  Yun Yun Xiong; Vincent Mok
Journal:  J Aging Res       Date:  2011-08-23

Review 4.  Prevention and Management of Cerebral Small Vessel Disease.

Authors:  Vincent Mok; Jong S Kim
Journal:  J Stroke       Date:  2015-05-29       Impact factor: 6.967

5.  Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies.

Authors:  Elisa Cuadrado-Godia; Pratistha Dwivedi; Sanjiv Sharma; Angel Ois Santiago; Jaume Roquer Gonzalez; Mercedes Balcells; John Laird; Monika Turk; Harman S Suri; Andrew Nicolaides; Luca Saba; Narendra N Khanna; Jasjit S Suri
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

Review 6.  Small Vessel Disease: Ancient Description, Novel Biomarkers.

Authors:  Rita Moretti; Paola Caruso
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

7.  Clinical and Neuropsychological Characteristics of a Nationwide Hospital-Based Registry of Frontotemporal Dementia Patients in Korea: A CREDOS-FTD Study.

Authors:  Eun-Joo Kim; Kyung-Won Park; Jae-Hong Lee; SeongHye Choi; Jee H Jeong; Soo Jin Yoon; Byeong C Kim; Jay C Kwon; Bon D Ku; Seung Hyun Kim; Byung-Ok Choi; Duk L Na
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2014-07-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.